» Articles » PMID: 29940980

Assessing Health Status over Time: Impact of Recall Period and Anchor Question on the Minimal Clinically Important Difference of Copd Health Status Tools

Overview
Publisher Biomed Central
Specialty Public Health
Date 2018 Jun 27
PMID 29940980
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Minimal Clinically Important Difference (MCID) assesses what change on a measurement tool can be considered minimal clinically relevant. Although the recall period can influence questionnaire scores, it is unclear if it influences the MCID. This study is the first to examine longitudinally the impact of the recall period of an anchor question and its design on the MCID of COPD health status tools using the COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ) and the St. George's Respiratory Questionnaire (SGRQ).

Methods: Moderate to very severe COPD patients without respiratory co-morbidities were recruited during 3-week Pulmonary Rehabilitation (PR). CAT, CCQ and SGRQ were completed at baseline, discharge, 3, 6, 9 and 12 months. A 15-point Global Rating of Change scale (GRC) was completed at each follow-up. A five-point GRC was used as second anchor at 12 months. Mean change scores of a subset of patients indicating a minimal improvement on each of the anchor questions were considered the MCID. The MCID estimates over different time periods were compared with one another by evaluating the degree of overlap of Confidence Intervals (CI) adjusted for dependency.

Results: In total 451 patients were included (57.9 ± 6.6 years, 65% male, 50/39/11% GOLD II/III/IV), of which 309 completed follow-up. Baseline health status scores were 20.2 ± 7.3 (CAT), 2.9 ± 1.2 (CCQ) and 50.7 ± 17.3 (SGRQ). MCID estimates for improvement ranged - 3.1 to - 1.4 for CAT, - 0.6 to - 0.3 for CCQ, and - 10.3 to - 7.6 for SGRQ. Absolute higher - though not significant - MCIDs were observed for CAT and CCQ directly after PR. Significantly absolute lower MCID estimates were observed for CAT (difference - 1.4: CI -2.3 to - 0.5) and CCQ (difference - 0.2: CI -0.3 to -0.1) using a five-point GRC.

Conclusions: The recall period of a 15-point anchor question seemed to have limited impact on the MCID for improvement of CAT, CCQ and SGRQ during PR; although a 3-week MCID estimate directly after PR might lead to absolute higher values. However, the design of the anchor question was likely to influence the MCID of CAT and CCQ.

Trial Registration: RIMTCORE trial # DRKS00004609 and #12107 (Ethik-Kommission der Bayerischen Landesärztekammer).

Citing Articles

Predictors of Quality-of-Life Improvement at Different Minimum Clinically Important Difference Values in Patients with Chronic Obstructive Pulmonary Disease after Climatic Rehabilitation Treatment.

Kubincova A, Takac P, Demjanovic Kendrova L, Joppa P Life (Basel). 2023; 13(8).

PMID: 37629620 PMC: 10455286. DOI: 10.3390/life13081763.


Determining the Minimal Important Difference for the Wound-QoL Questionnaire.

Topp J, Blome C, Augustin M, Mohr N, Debus E, Diener H Patient Prefer Adherence. 2021; 15:1571-1578.

PMID: 34285475 PMC: 8286720. DOI: 10.2147/PPA.S315822.


Brazilian version of the Clinical COPD Questionnaire, administered by interview: reliability and validity measurement properties.

Re A, Fonseca F, Queiroz A, Reis C, Bahl M, Kocks J J Bras Pneumol. 2021; 47(3):e20200371.

PMID: 34076173 PMC: 8332715. DOI: 10.36416/1806-3756/e20200371.


Commentary: "Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease" by Dankers M et al. in 2020; 10: 1519.

Alma H, de Jong C, Kocks J, van der Molen T Front Pharmacol. 2020; 11:827.

PMID: 32581793 PMC: 7280745. DOI: 10.3389/fphar.2020.00827.


Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.

Bae E, Choi S, Lee H, Shin G, Kang D BMC Pulm Med. 2020; 20(1):73.

PMID: 32293387 PMC: 7092534. DOI: 10.1186/s12890-020-1116-z.


References
1.
Meek P, Lareau S, Anderson D . Memory for symptoms in COPD patients: how accurate are their reports?. Eur Respir J. 2001; 18(3):474-81. DOI: 10.1183/09031936.01.00083501. View

2.
Guyatt G, Feeny D, Patrick D . Measuring health-related quality of life. Ann Intern Med. 1993; 118(8):622-9. DOI: 10.7326/0003-4819-118-8-199304150-00009. View

3.
Kocks J, Tuinenga M, Uil S, van den Berg J, Stahl E, van der Molen T . Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006; 7:62. PMC: 1508149. DOI: 10.1186/1465-9921-7-62. View

4.
Norquist J, Girman C, Fehnel S, Demuro-Mercon C, Santanello N . Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration. Qual Life Res. 2011; 21(6):1013-20. DOI: 10.1007/s11136-011-0003-8. View

5.
Kon S, Canavan J, Jones S, M Nolan C, Clark A, Dickson M . Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014; 2(3):195-203. DOI: 10.1016/S2213-2600(14)70001-3. View